Zinc metabolism in infection

Area of Science:

• Infectious Diseases
• Metabolic Processes
• Immunology

Background:

• Zinc metabolism undergoes significant changes during infections, involving early redistribution and later direct losses.
• Plasma zinc concentrations often decrease with illness onset, preceding or coinciding with observed changes.
• While direct confirmation via metabolic balance studies during infection is limited, inferred losses occur through urinary excretion, sweat, or diarrhea.

Purpose of the Study:

• To investigate the sequential changes in zinc metabolism during infectious illnesses.
• To identify the role of Leukocytic Endogenous Mediator (LEM) in initiating zinc redistribution.
• To evaluate the potential host defense functions of early zinc redistribution and the efficacy of zinc therapy.

Main Methods:

• Analysis of sequential changes in zinc metabolism during infection.
• Separation of Leukocytic Endogenous Mediator (LEM) from other substances released by phagocytic cells.
• Review of experimental data on zinc therapy in animal models of infectious diseases.

Main Results:

• Infections trigger early zinc redistribution and subsequent direct zinc losses.
• Leukocytic endogenous mediator (LEM) appears to be a key factor in initiating early zinc redistribution.
• Early zinc redistribution may enhance host defense mechanisms, including cellular membrane stability and immune cell function.
• Experimental studies in animal models have not demonstrated beneficial effects of zinc therapy for infectious diseases.

Conclusions:

• Infectious illnesses induce complex changes in zinc metabolism, characterized by redistribution and loss.
• Leukocytic endogenous mediator (LEM) plays a role in the early stages of infection-related zinc shifts.
• Early zinc redistribution may represent a physiological defense mechanism.
• Zinc therapy has not shown efficacy in animal models of infectious diseases, suggesting caution in its application.